Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.25
-0.5700-1.64%
Pre-market: 34.00-0.2500-0.73%07:49 EDT
Volume:37.89K
Turnover:1.30M
Market Cap:95.22M
PE:- -
High:34.47
Open:34.47
Low:34.04
Close:34.82
52wk High:36.84
52wk Low:23.42
Shares:2.78M
Float Shares:2.78M
Volume Ratio:2.12
T/O Rate:1.36%
Dividend:0.26
Dividend Rate:0.75%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

TIPRANKS
·
57 mins ago

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Dow Jones
·
57 mins ago

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Reuters
·
1 hour ago

CSPC Pharma Initiates Phase II Clinical Trial of SYH2069 Injection for Type 2 Diabetes at First Chinese Study Center

Stock News
·
1 hour ago

Beijing Sun-Novo Secures Clinical Trial Approval for Heart Failure Treatment Candidate BTP0427

Stock News
·
2 hours ago

ST Bailing's Subsidiary Receives Clinical Trial Approval for Tangning Tongluo Cream

Stock News
·
3 hours ago

Hong Kong Stock Market Update: Hengrui Pharma Surges Nearly 4% in Late Trading Following Dual Clinical Trial Approvals

Stock News
·
4 hours ago

Hong Kong Policy Address: Northern Metropolis Accelerates with Mainland Partnerships and Clinical Trial Hub Launch

Deep News
·
7 hours ago

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Reuters
·
8 hours ago

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Reuters
·
15 hours ago

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live
·
Yesterday

Gilead announces agreement with PAHO for lenacapavir access

TIPRANKS
·
Yesterday

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS
·
Yesterday

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS
·
Yesterday

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS
·
Yesterday

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Reuters
·
Yesterday

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS
·
Yesterday

Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call

THOMSON REUTERS
·
Yesterday

Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call

THOMSON REUTERS
·
Yesterday

Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17

Reuters
·
Yesterday